Device Catheters - Otw Embolectomy

Lemaitre Embolectomy Catheter

Payments companies reported to CMS as associated with Lemaitre Embolectomy Catheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$452associated payments (2023-2025)
19clinicians with associated payments
1company reporting

By year

2023 $118
2024 $119
2025 $214

Payments reported as associated with Lemaitre Embolectomy Catheter, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $169
Vascular Surgery $134
Nephrology (Internal Medicine) $55.79
Family $19.17
Physician Assistant $19.17
Diagnostic Radiology $19.00

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Lemaitre Embolectomy Catheter

These are the largest totals companies reported as associated with Lemaitre Embolectomy Catheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jilbert Eradat Los Angeles, CA Vascular & Interventional Radiology $124.00
Wayne Cheng Stanford, CA Vascular & Interventional Radiology $23.82
Joshua Herbert New York, NY Nephrology (Internal Medicine) $21.08
Ted Lao New York, NY Nephrology (Internal Medicine) $21.08
Mario Cedillo Palmdale, CA Vascular & Interventional Radiology $20.90
Brandi Brooks Erie, PA Family $19.17
Aaron Kleps Erie, PA Physician Assistant $19.17
Carleen Cho Erie, PA Vascular Surgery $19.17
Christopher Moran Manhasset, NY Diagnostic Radiology $19.00
Alyssa Roman Toms River, NJ Acute Care (Nurse Practitioner) $19.00

Prescribed Lemaitre Embolectomy Catheter?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.